Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #6,551 to #6,600.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Crtn [212 bytes]
  2. (hist) SERM [212 bytes]
  3. (hist) Parietal branch [212 bytes]
  4. (hist) Chromatoidal bodies [212 bytes]
  5. (hist) External sphincter muscle of urethra [212 bytes]
  6. (hist) Sexual penetration [212 bytes]
  7. (hist) Drug treatment [212 bytes]
  8. (hist) Hydrocodone indications [212 bytes]
  9. (hist) Pheochromocytoma cost-effectiveness of therapy [212 bytes]
  10. (hist) Gonadoblastoma echocardiography or ultrasound [212 bytes]
  11. (hist) Malignant fibrous histiocytoma causes [212 bytes]
  12. (hist) Mental disorder pathophysiology [212 bytes]
  13. (hist) Mental disorder screening [212 bytes]
  14. (hist) Mental disorder physical examination [212 bytes]
  15. (hist) Mental disorder laboratory findings [212 bytes]
  16. (hist) Mental disorder electrocardiogram [212 bytes]
  17. (hist) Mental disorder CT [212 bytes]
  18. (hist) Mental disorder MRI [212 bytes]
  19. (hist) Mental disorder other imaging findings [212 bytes]
  20. (hist) Mental disorder other diagnostic studies [212 bytes]
  21. (hist) Mental disorder surgery [212 bytes]
  22. (hist) Mental disorder prevention [212 bytes]
  23. (hist) Mental disorder cost-effectiveness of therapy [212 bytes]
  24. (hist) Mental disorder future or investigational therapies [212 bytes]
  25. (hist) Mental disorder case study one [212 bytes]
  26. (hist) Alagille syndrome electrocardiogram [212 bytes]
  27. (hist) Alagille syndrome historical perspective [212 bytes]
  28. (hist) Alagille syndrome differential diagnosis [212 bytes]
  29. (hist) Alagille syndrome CT [212 bytes]
  30. (hist) Alagille syndrome cost-effectiveness of therapy [212 bytes]
  31. (hist) Alagille syndrome future or investigational therapies [212 bytes]
  32. (hist) Miosis classification [212 bytes]
  33. (hist) Miosis risk factors [212 bytes]
  34. (hist) Miosis MRI [212 bytes]
  35. (hist) Miosis other imaging findings [212 bytes]
  36. (hist) Miosis secondary prevention [212 bytes]
  37. (hist) Miosis cost-effectiveness of therapy [212 bytes]
  38. (hist) Miosis future or investigational therapies [212 bytes]
  39. (hist) Hematemesis epidemiology and demographics [212 bytes]
  40. (hist) Proctalgia fugax cost-effectiveness of therapy [212 bytes]
  41. (hist) Proctalgia fugax future or investigational therapies [212 bytes]
  42. (hist) Proctalgia fugax case study one [212 bytes]
  43. (hist) Ascending cholangitis case study one [212 bytes]
  44. (hist) Mirizzi's syndrome case study one [212 bytes]
  45. (hist) Mirizzi's syndrome cost-effectiveness of therapy [212 bytes]
  46. (hist) Mirizzi's syndrome future or investigational therapies [212 bytes]
  47. (hist) AVNRT ablation [212 bytes]
  48. (hist) Hyperprolactinemia surgery [212 bytes]
  49. (hist) Aplastic anemia MRI [212 bytes]
  50. (hist) Lactose intolerance case study one [212 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ShortPages"